openPR Logo
Press release

Psoriasis Treatment Market: Industry Survey and Outlook 2024

06-23-2017 06:02 PM CET | Health & Medicine

Press release from: Transparency Market Research

Psoriasis Treatment Market: Industry Survey and Outlook 2024

Global Psoriasis Treatment Market: Snapshot

The alarming rise in the number of psoriasis patients is having the most prominent impact on the global market for psoriasis treatment. With the increasing FDA approval for novel drugs and therapies for psoriasis treatment, the market is likely to surge remarkably over the next few years. Apart from this, the presence of a strong product pipeline and the growing awareness regarding psoriasis and its treatment among people in emerging economies are also projected to propel this market in the near future.

View Report @ http://www.transparencymarketresearch.com/psoriasis-treatment-market.html

According to Transparency Market Research (TMR), the global market for psoriasis treatment offered an opportunity worth US$7.8 bn in 2015. Researchers estimate this market to rise at a CAGR of 5.10% between 2016 and 2024 and reach US$12.1 bn by 2024.

TNF Inhibitors Report Higher Demand

TNF Inhibitors, interleukin blockers, and vitamin D analogues or combination have emerged as the key products available in the worldwide market for psoriasis treatment. Driven by superior efficiency and safety, TNF inhibitors are reporting a higher demand than other products in this market. By 2024, the segment is expected to remain on top with an estimated share of more than 47% in the overall market. However, the introduction of biosimilars may limit this demand to some extent in the years to come.

Interleukin blockers, on the flip side, is projected to present a lucrative growth opportunity to market players over the coming years due to their augmenting usage and their ability to act selectively by targeting the proteins.

Increasing Pool of Psoriasis Patients to Ensure North America’s Dominance

On the basis of geography, Latin America, North America, Europe, Middle East and Africa, and Asia Pacific are considered as the prime regional market for psoriasis treatment. North America has surfaced as the key contributor to this market and is likely to retain this position in the near future. The remarkable rise in the patient pool suffering from psoriasis is projected to boost this regional market over the coming years. The presence of well-established drugmakers is also expected to have positive influence on the North America market for psoriasis treatment in the years to come.

Get accurate market forecast and analysis on the Psoriasis Treatment Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17960

Europe, although currently having a strong position in the overall market, is likely to experience a decline in the demand psoriasis treatment, following an intense competition from biosimilars over the next few years. Latin America and Asia Pacific, on the other hand, are anticipated to witness a significant rise in their respective markets over the next few years. The increasing awareness regarding psoriasis and its treatment among people in emerging economies, such as China and India, through various government and NGO campaigns is projected to stimulate the Asia Pacific market for psoriasis treatment considerably in the near future.

Biogen, LEO Pharma A/S, AbbVie Inc., AstraZeneca, Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Novartis AG, Eli Lilly & Co., and Amgen Inc. are some of the prominent players in the global market for psoriasis treatment.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Psoriasis Treatment Market: Industry Survey and Outlook 2024 here

News-ID: 594837 • Views: 380

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for Psoriasis

Psoriasis Treatment Market - Innovations & Future Market Trends
Psoriasis is non-communicable autoimmune inflammatory, chronic, and painful skin disease characterized by abnormal skin patches. These skin patches are scaly, red, and itchy. These patches may be small and either localized or encompass the entire body. At present, there is no cure for this disease and the major goal of treatment is to limit inflammation and formation of abnormal skin plaque. Factors such as rising disease prevalence, significant unmet
Latest pipeline Psoriasis Market Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H2 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape. Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up skin, itchiness, and burning sensation, swollen and stiff joints. Predisposing factors include heredity, side effects of certain medicines, stress, infections and environmental conditions. The
Global Psoriasis Industrial and Market Analysis with Focus on Plaque Psoriasis: …
"Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed
Psoriasis Treatment Market: Analysis & Trends 2024
Global Psoriasis Treatment Market - Overview This report on the Psoriasis Treatment market analyzes the current and future scenario of the global market. Approval of new biologics, increase in access for the treatment in developing market, increase in the number of psoriasis patients, are boosting the growth of the global Psoriasis Treatment market. Increase in the incidence of Psoriasis and skin disorders, and novel pipeline drugs are some of the factors
Psoriasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Psoriasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H1 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape. Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It